Leming Shi - Citegraph

Author Info

Name	Affiliation	Papers
LEMING SHI	Division of Systems Toxicology, National Center for Toxicological Research, US FDA, Jefferson, AR 72079, USA	16
Collaborators	Citations	PageRank
96	408	23.69
Referers	Referees	References
941	328	95

Search Limit

100941

Publications (16 rows)

Collaborators (96 rows)

Referers (100 rows)

Referees (100 rows)

Title	Citations	PageRank	Year
Selecting a single model or combining multiple models for microarray-based classifier development?--a comparative analysis based on large and diverse datasets generated from the MAQC-II project.	14	0.40	2011
Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles.	20	0.51	2009
Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples.	33	0.70	2008
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies.	10	2.01	2008
Very Important Pool (VIP) genes--an application for microarray-based molecular signatures.	32	0.49	2008
Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.	28	1.23	2006
Improvement in the reproducibility and accuracy of DNA microarray quantification by optimizing hybridization conditions.	30	0.62	2006
Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale).	26	0.89	2006
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential.	59	4.01	2005
Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling.	39	1.53	2005
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).	8	0.93	2005
A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools.	29	0.56	2005
Microarray scanner calibration curves: characteristics and implications.	39	2.96	2005
QSAR Models Using a Large Diverse Set of Estrogens.	15	1.64	2001
Mining and Visualizing Large Anticancer Drug Discovery Databases.	10	2.23	2000
Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues.	16	2.99	1998

1